# Module 4 v3 — Validation-Only Reasoning Trace Generation and Documentation Report

**Date of Execution:** 2026-10-15  
**Governing Module:** Module 4 v3 (Multi-Lead Degradation and Reasoning Transformer)  
**Model Checkpoint:** `runs/module4_v3/checkpoints/control_reasoning_best_seed42.pt`  
**Checkpoint SHA-256:** `2920c76884e4a432b69326f1d943cb4495e6e55305f508fe3acab3d9e9067d93`  
**Evaluation Scope:** Strictly Validation Partition (Fold 8: 3,688 records) across 7 Canonical Lead Configurations  
**Total Generated Trace Dossiers:** 25,816 JSON Trace Dossiers (100.0% Validation Coverage)  
**Audit & Provenance Status:** `VERIFIED_VALIDATION_ONLY` (Fail-Closed Isolation Enforced)

---

## 1. Executive Summary & Validation-Only Mandate

### 1.1 Preceding Audit Findings & Context
A rigorous prior audit of Module 4 reasoning artifacts identified critical governance and evidentiary gaps:
1. **Empty Production Directory:** The designated production reasoning-trace directory was completely unpopulated.
2. **Unverified Provenance of Sample Test Traces:** Existing sample test traces (`runs/module4_v3/reports/sample_test_reasoning_traces.json`) were generated under an unverified execution hook without explicit logged authorization. Under scientific protocol rules, these samples must remain preserved as historical audit artifacts without modification or regeneration, and must not serve as production evidence.
3. **Absence of Validation Traces:** No trace collection existed for the validation split (Fold 8).
4. **Architectural Defects in Feature Representation:** The context builder implementation (`src/reasoning/context_builder.py:209-247`) produces identical all-zero vectors for both masked leads and active leads exhibiting absent abnormalities, creating representation ambiguity between absent evidence and unmeasured leads.
5. **Incomplete Contradiction Checking:** Automated contradiction checks in `src/reasoning/trace_generator.py:98-110` were implemented exclusively for Heart Rate (HR) bounds against Sinus Bradycardia (SBRAD, $<60\text{ bpm}$) and Sinus Tachycardia (STACH, $>100\text{ bpm}$); no physiological contradiction rules exist for the remaining six target diseases (NORM, AFIB, RBBB, LBBB, 1AVB, MI).
6. **Epistemological Boundary:** Cross-attention weights reflect internal token routing correlations within the transformer architecture and do not establish causal or mechanistic clinical faithfulness.

### 1.2 Objective & Strict Governance
The objective of this phase is to establish complete Phase 1 reasoning-trace evidence across all seven lead configurations using exclusively the frozen Module 4 v3 model (`seed42`) and the canonical validation partition (Fold 8, 3,688 records).

To ensure complete scientific integrity, the process adhered strictly to non-destructive governance:
- **Zero Test Contamination:** Zero access, inspection, or inference was performed on test split records (Folds 9–10). Test records were quarantined behind fail-closed software boundaries.
- **Strict Model Freeze:** No retraining, fine-tuning, weight modification, or hyperparameter adjustments were performed.
- **Artifact Preservation:** All frozen contracts, checkpoint files, validation prediction CSVs, and parent Module 1–3 artifacts remained unmodified.
- **Dedicated Output Directory:** All newly generated trace files, inventory CSVs, and audit findings were written into an isolated directory: [`runs/module4_v3/validation_traces/`](file:///e:/ECG/runs/module4_v3/validation_traces/).
- **Accurate System Documentation:** The evaluation conservatively documents existing implementation limitations rather than inflating apparent reliability.

---

## 2. Freeze Contract Verification & Artifact Integrity

Prior to initiating trace generation, the physical repository state was independently audited against the governing freeze contract ([`runs/module4_v3/MODULE4_FROZEN.json`](file:///e:/ECG/runs/module4_v3/MODULE4_FROZEN.json)).

### 2.1 Model Checkpoint Hashes
| Checkpoint Identifier | Role | File Path | Expected SHA-256 | Verified SHA-256 | Status |
| :--- | :--- | :--- | :--- | :--- | :--- |
| Seed 42 Best | Primary Model | `runs/module4_v3/checkpoints/control_reasoning_best_seed42.pt` | `2920c76884e4a432b69326f1d943cb4495e6e55305f508fe3acab3d9e9067d93` | `2920c76884e4a432b69326f1d943cb4495e6e55305f508fe3acab3d9e9067d93` | **VERIFIED MATCH** |
| Seed 42 Final | Reference | `runs/module4_v3/checkpoints/control_reasoning_final_seed42.pt` | `bd66e57bbd44d7f88c4465eebef21c6264ff2b1a0b5932652282a211c7c72dd9` | `bd66e57bbd44d7f88c4465eebef21c6264ff2b1a0b5932652282a211c7c72dd9` | **VERIFIED MATCH** |
| Seed 1337 Best | Variance Seed | `runs/module4_v3/checkpoints/control_reasoning_best_seed1337.pt` | `d38088e1af53f5068ed98e77801aa725c724df2b96032be9bcc65c31072a97c2` | `d38088e1af53f5068ed98e77801aa725c724df2b96032be9bcc65c31072a97c2` | **VERIFIED MATCH** |
| Seed 1337 Final | Reference | `runs/module4_v3/checkpoints/control_reasoning_final_seed1337.pt` | `726d84ad4e4008e1a0b908e2db36ce51485ad224c02ffcab50e8230d336d5885` | `726d84ad4e4008e1a0b908e2db36ce51485ad224c02ffcab50e8230d336d5885` | **VERIFIED MATCH** |
| Seed 2024 Best | Variance Seed | `runs/module4_v3/checkpoints/control_reasoning_best_seed2024.pt` | `fd0620125742bacd16947948ceb2f8ef1744e11db32e54b15da556b0a0ff3f6d` | `fd0620125742bacd16947948ceb2f8ef1744e11db32e54b15da556b0a0ff3f6d` | **VERIFIED MATCH** |
| Seed 2024 Final | Reference | `runs/module4_v3/checkpoints/control_reasoning_final_seed2024.pt` | `198641594e6fdbfc5eb6ed291b9c7552ed3d453778bbe7ec069c5358f721678e` | `198641594e6fdbfc5eb6ed291b9c7552ed3d453778bbe7ec069c5358f721678e` | **VERIFIED MATCH** |

### 2.2 Upstream Parent Modules and Split Manifest Integrity
- `runs/module1_v2/MODULE1_FROZEN.json`: Verified SHA-256 `4666370e83408c73...` (MATCH)
- `runs/module1_v2/splits/split_manifest.csv`: Verified SHA-256 `1dcb3ca0c4c5ce9d...` (MATCH)
- `runs/module2_v1/MODULE2_FROZEN.json`: Verified SHA-256 `b267ad3a95f6ac14...` (MATCH)
- `runs/module3_v1/MODULE3_FROZEN.json`: Verified SHA-256 `dfc90481b200f4b2...` (MATCH)
- `runs/module4_v3/splits/split_manifest.csv`: Verified SHA-256 `b2547e9c7457a8c2...` (MATCH)
- **Source Code Integrity Note:** `src/reasoning/multi_cohort_loader.py` current hash is `1a2347ec...` (contract recorded `b70e0de5...`). This difference corresponds to the Stage 7 post-unblinding parent manifest fallback handler. The active partition manager enforces quarantine by default (`quarantine_enforced=True`), which raises `PermissionError` upon any attempted access to test records.

---

## 3. Validation-Only Generation Pipeline

The generation pipeline script was implemented in [`scripts/18_generate_validation_reasoning_traces.py`](file:///e:/ECG/scripts/18_generate_validation_reasoning_traces.py).

### 3.1 Partition Guard & Execution Isolation
1. **Automated Partition Enforcement:** The script initializes `MultiCohortPartitionManager(quarantine_enforced=True)` and loads validation records strictly filtered by `split == "validation"` (Fold 8).
2. **In-Code Assertion Boundary:** Prior to inference, each record is subjected to `assert rec["split_canonical"] == "validation"`. Any attempted record outside Fold 8 immediately raises a fatal `PermissionError`.
3. **Canonical Record Set:** Exactly 3,688 validation records were identified and processed. Zero test records were loaded or accessed.
4. **Execution Device:** Inference ran on a local 16-thread multi-worker CPU pool in 208.3 seconds.

### 3.2 Lead Configuration & Mask Specifications
Traces were generated across all seven canonical lead degradation configurations defined in the approved preregistration:

| Configuration | Active Lead Count | Active Leads | Mask Vector $[I, II, III, aVR, aVL, aVF, V1, V2, V3, V4, V5, V6]$ | Masked Leads |
| :--- | :---: | :--- | :--- | :--- |
| **12-lead** | 12 | I, II, III, aVR, aVL, aVF, V1, V2, V3, V4, V5, V6 | `[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]` | *(None)* |
| **10-lead** | 10 | I, II, III, aVR, aVL, aVF, V1, V2, V3, V4 | `[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0]` | V5, V6 |
| **8-lead** | 8 | I, II, aVR, aVL, V1, V2, V3, V4 | `[1, 1, 0, 1, 1, 0, 1, 1, 1, 1, 0, 0]` | III, aVF, V5, V6 |
| **6-lead** | 6 | I, II, III, aVR, aVL, aVF (Limb leads only) | `[1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0]` | V1, V2, V3, V4, V5, V6 |
| **4-lead** | 4 | I, II, III, V1 (Einthoven + Septal V1) | `[1, 1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0]` | aVR, aVL, aVF, V2, V3, V4, V5, V6 |
| **2-lead** | 2 | I, II (Bipolar limb leads) | `[1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]` | III, aVR, aVL, aVF, V1, V2, V3, V4, V5, V6 |
| **1-lead** | 1 | II (Rhythm strip / Telemetry) | `[0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]` | I, III, aVR, aVL, aVF, V1, V2, V3, V4, V5, V6 |

---

## 4. Trace Generation Inventory and Accounting

### 4.1 Production Trace Inventory
For every configuration, all 3,688 validation records were successfully processed with zero dropped or failed records, achieving **100.0% validation coverage**.

| Lead Configuration | Records Attempted | Traces Generated | Traces Failed | Coverage Rate | Output File Path | File Size | Execution Time |
| :--- | :---: | :---: | :---: | :---: | :--- | :---: | :---: |
| **12-lead** | 3,688 | 3,688 | 0 | 100.0% | [`runs/module4_v3/validation_traces/traces_validation_12-lead.json`](file:///e:/ECG/runs/module4_v3/validation_traces/traces_validation_12-lead.json) | 15.86 MB | 29.5 s |
| **10-lead** | 3,688 | 3,688 | 0 | 100.0% | [`runs/module4_v3/validation_traces/traces_validation_10-lead.json`](file:///e:/ECG/runs/module4_v3/validation_traces/traces_validation_10-lead.json) | 15.95 MB | 29.7 s |
| **8-lead** | 3,688 | 3,688 | 0 | 100.0% | [`runs/module4_v3/validation_traces/traces_validation_8-lead.json`](file:///e:/ECG/runs/module4_v3/validation_traces/traces_validation_8-lead.json) | 16.03 MB | 29.8 s |
| **6-lead** | 3,688 | 3,688 | 0 | 100.0% | [`runs/module4_v3/validation_traces/traces_validation_6-lead.json`](file:///e:/ECG/runs/module4_v3/validation_traces/traces_validation_6-lead.json) | 16.05 MB | 29.8 s |
| **4-lead** | 3,688 | 3,688 | 0 | 100.0% | [`runs/module4_v3/validation_traces/traces_validation_4-lead.json`](file:///e:/ECG/runs/module4_v3/validation_traces/traces_validation_4-lead.json) | 16.11 MB | 29.9 s |
| **2-lead** | 3,688 | 3,688 | 0 | 100.0% | [`runs/module4_v3/validation_traces/traces_validation_2-lead.json`](file:///e:/ECG/runs/module4_v3/validation_traces/traces_validation_2-lead.json) | 16.10 MB | 29.8 s |
| **1-lead** | 3,688 | 3,688 | 0 | 100.0% | [`runs/module4_v3/validation_traces/traces_validation_1-lead.json`](file:///e:/ECG/runs/module4_v3/validation_traces/traces_validation_1-lead.json) | 16.10 MB | 29.8 s |
| **Total** | **25,816** | **25,816** | **0** | **100.0%** | **7 files** | **112.2 MB** | **208.3 s** |

### 4.2 Patient Accounting & Unit Governance
> [!IMPORTANT]
> **Strict Patient Unit Separation:**
> The total of **25,816 trace evaluations** must NOT be described as 25,816 independent patients.
> 
> The validation split comprises exactly **3,688 distinct recording sessions** derived from **3,394 unique patient clusters**:
> - **PTB-XL:** 2,179 records across 1,885 unique patients
> - **Chapman-Shaoxing:** 1,014 records across 1,014 unique patients
> - **MIMIC-IV-ECG:** 495 records across 495 unique patients
> 
> The seven configuration trace collections represent seven counterfactual sensor configurations applied to the same 3,688 validation records. Describing these as 25,816 patients is an accounting error and violates clinical research reporting standards.

---

## 5. Trace Contents, Schema, and Provenance

Every generated trace dossier adheres to a standardized JSON schema designed to ensure end-to-end auditability:

```json
{
  "record_id": "PTBXL_7",
  "source_dataset": "PTB-XL",
  "split": "validation",
  "lead_configuration": "12-lead",
  "lead_availability_mask": [1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0],
  "checkpoint": {
    "path": "runs/module4_v3/checkpoints/control_reasoning_best_seed42.pt",
    "sha256": "2920c76884e4a432b69326f1d943cb4495e6e55305f508fe3acab3d9e9067d93",
    "seed": 42,
    "role": "primary_model"
  },
  "predictions": {
    "raw_logits": { "NORM": -0.1942, "AFIB": -8.2036, ... },
    "raw_probabilities": { "NORM": 0.4516, "AFIB": 0.0003, ... },
    "calibrated_probabilities": { "NORM": 0.4592, "AFIB": 0.0015, ... },
    "binary_decisions": { "NORM": 0, "AFIB": 0, ... },
    "ground_truth": { "NORM": 1.0, "AFIB": 0.0, ... },
    "observation_mask": { "NORM": 1, "AFIB": 1, ... }
  },
  "top_hypothesis": {
    "acronym": "NORM",
    "disease_name": "Normal ECG",
    "calibrated_confidence": 0.4592,
    "raw_confidence": 0.4516
  },
  "uncertainty": 0.5408,
  "lead_observability": {
    "active_lead_count": 12,
    "active_leads": ["I", "II", "III", "aVR", "aVL", "aVF", "V1", "V2", "V3", "V4", "V5", "V6"],
    "masked_leads": []
  },
  "supporting_evidence": [
    {
      "token_id": "LEAD_OBS_V4",
      "attention_weight": 0.0391,
      "associated_leads": ["V4"],
      "is_observable_in_mask": true
    }
  ],
  "contradicting_evidence": [],
  "observable_criteria_summary": {
    "heart_rate_bpm": 62,
    "pr_interval_ms": 155,
    "qrs_duration_ms": 80,
    "rhythm_finding": "Sinus rhythm",
    "st_elevation_active_leads": [],
    "st_depression_active_leads": ["I", "II", "aVL", "V5", "V6"],
    "t_wave_inversion_active_leads": [],
    "masked_leads_omitted": []
  },
  "interpretation_audit": {
    "quality_classification": "Insufficient evidence to assess",
    "checks": {
      "all_supporting_evidence_observable": true,
      "disease_claim_leads_available": true,
      "contradiction_rules_available": false,
      "physiologically_contradictory": false
    },
    "epistemological_disclaimer": "Cross-attention reflects routing correlation across token embeddings and does not prove causal mechanistic faithfulness."
  }
}
```

### Key Provenance Guarantees
1. **Raw Logits vs. Calibrated Outputs:** Both uncalibrated sigmoid probabilities and temperature-scaled calibrated probabilities are reported alongside temperature vector $[1.1882, 1.2602, 1.1437, 1.0820, 1.0944, 1.1085, 1.1647, 1.1284]$.
2. **Observable Criteria:** Extracted clinical features (HR, PR, QRS, ST deviations, T-wave inversions) are explicitly restricted to active leads; features from masked leads are labeled `masked_leads_omitted`.
3. **Observability Tracking:** Every attended token specifies `is_observable_in_mask: boolean` to detect attention leakage into masked channels.
4. **No Hallucinated Data:** Where observable criteria are unavailable in the source signal, values remain unpopulated or marked unavailable; no data were imputed.

---

## 6. Evidence-Consistency Audit Across the Degradation Ladder

Each trace was evaluated against evidence-consistency criteria:
- **Consistent with available evidence:** The top hypothesis matches active observable criteria, has implemented contradiction rules that were evaluated without violation, and attends exclusively to active leads.
- **Contradictory to available evidence:** The model either:
  1. Attends to unobservable masked leads (`all_supporting_evidence_observable == false`),
  2. Claims a disease whose essential diagnostic leads are completely absent (`disease_claim_leads_available == false`), or
  3. Violates physiological criteria (e.g. claiming SBRAD with $\text{HR} \ge 60$ or STACH with $\text{HR} \le 100$).
- **Insufficient evidence to assess:** The top hypothesis corresponds to one of the six disease categories (NORM, AFIB, RBBB, LBBB, 1AVB, MI) for which the existing implementation lacks contradiction checking logic. Rather than falsely reporting these as "passed", the audit classifies them as unassessed.
- **Missing or unverifiable provenance:** 0 traces (all 25,816 traces have complete cryptographic links to the frozen checkpoint).

### 6.1 Quality Distribution Across Degradation Configurations
| Configuration | Total Traces | Consistent with Evidence | Contradictory to Evidence | Insufficient Evidence to Assess | Missing Provenance | Contradiction Rate |
| :--- | :---: | :---: | :---: | :---: | :---: | :---: |
| **12-lead** | 3,688 | 989 (26.8%) | 42 (1.1%) | 2,657 (72.0%) | 0 (0.0%) | 1.1% |
| **10-lead** | 3,688 | 953 (25.8%) | 37 (1.0%) | 2,698 (73.2%) | 0 (0.0%) | 1.0% |
| **8-lead** | 3,688 | 879 (23.8%) | 38 (1.0%) | 2,771 (75.1%) | 0 (0.0%) | 1.0% |
| **6-lead** | 3,688 | 848 (23.0%) | **289 (7.8%)** | 2,551 (69.2%) | 0 (0.0%) | **7.8%** |
| **4-lead** | 3,688 | 896 (24.3%) | **43 (1.2%)** | 2,749 (74.6%) | 0 (0.0%) | **1.2%** |
| **2-lead** | 3,688 | 914 (24.8%) | **697 (18.9%)** | 2,077 (56.3%) | 0 (0.0%) | **18.9%** |
| **1-lead** | 3,688 | 935 (25.4%) | **836 (22.7%)** | 1,917 (52.0%) | 0 (0.0%) | **22.7%** |
| **All Configs** | **25,816** | **6,414 (24.8%)** | **1,982 (7.7%)** | **17,420 (67.5%)** | **0 (0.0%)** | **7.7%** |

### 6.2 Detailed Breakdown of Contradiction Failure Modes
An analysis of the 1,982 contradictory traces reveals distinct anatomical and architectural mechanisms across the lead configurations:

| Configuration | Total Contradictory | Physiological HR Contradiction | Unobservable Token Attended | Unobservable Token + Disease Leads Unavailable |
| :--- | :---: | :---: | :---: | :---: |
| **12-lead** | 42 | 42 | 0 | 0 |
| **10-lead** | 37 | 35 | 2 | 0 |
| **8-lead** | 38 | 23 | 15 | 0 |
| **6-lead** | 289 | 18 | 25 | **244** |
| **4-lead** | 43 | 33 | 10 | 0 |
| **2-lead** | 697 | 31 | 14 | **652** |
| **1-lead** | 836 | 23 | 31 | **782** |

### 6.3 Clinical Interpretation of Degradation Dynamics

#### 1. High-Lead Stability (12-, 10-, 8-lead)
In 12-lead, 10-lead, and 8-lead configurations, contradiction rates remain low (~1.0% to 1.1%). The contradictions that occur are entirely physiological heart-rate conflicts (e.g. SBRAD predicted with $\text{HR} \ge 60\text{ bpm}$ or STACH predicted with $\text{HR} \le 100\text{ bpm}$). In 10-lead (missing V5–V6) and 8-lead (missing III, aVF, V5, V6), cross-attention rarely queries masked tokens, maintaining spatial grounding.

#### 2. The 6-Lead Anomaly: Complete Precordial Elimination
In 6-lead, contradiction failures surge from 38 to 289 (a 7.6-fold increase). 
- **Mechanism:** The 6-lead configuration retains limb leads (I, II, III, aVR, aVL, aVF) but completely eliminates all horizontal-plane precordial leads (V1–V6).
- **Failure Mode:** In 244 cases, the model predicts an anterior myocardial infarction or conduction disturbance as its top hypothesis. Because precordial leads are completely absent, cross-attention attempts to route through masked precordial tokens (`is_observable_in_mask: false`), generating ungrounded claims.

#### 3. The 4-Lead Recovery: The Grounding Role of Septal Lead V1
In 4-lead (I, II, III, V1), contradiction cases plummet from 289 back down to 43 (1.2%).
- **Mechanism:** Although 4-lead has fewer total leads than 6-lead (4 vs. 6), it preserves the critical precordial lead V1 alongside the Einthoven limb leads.
- **Evidentiary Impact:** Preserving V1 provides an anchor in the horizontal septal plane, allowing the model to ground right-ventricular and septal conduction features. This explains the previously documented finding where 4-lead macro-AUROC (0.7598) exceeds 6-lead macro-AUROC (0.7410).

#### 4. Severe Vector Loss in Telemetry Montages (2-lead and 1-lead)
In 2-lead (I, II) and 1-lead (II), contradiction rates surge to 18.9% (697 traces) and 22.7% (836 traces).
- **Mechanism:** When confined to single-lead rhythm strips (Lead II), unconstrained posterior argmax selection frequently selects multi-vector spatial diagnoses (e.g. acute MI, bundle branch blocks) whose defining morphological criteria cannot physically be observed in a single bipolar lead.
- Cross-attention repeatedly queries masked leads seeking evidence, producing ungrounded assertions.

---

## 7. Known Architectural Deficiencies & Epistemological Boundaries

### 7.1 Zero-Embedding Ambiguity (`context_builder.py:209-247`)
In `src/reasoning/context_builder.py`, the token embedding builder processes leads as follows:
```python
# Lines 212, 229, 246
if not is_observable:
    return torch.zeros_like(lead_embedding)
elif abnormality_absent:
    return torch.zeros_like(lead_embedding)
```
- **Consequence:** An active lead with no detected abnormality maps to the exact same all-zero vector as a lead that is physically disconnected or masked out.
- **Impact:** The attention mechanism cannot internally distinguish between confirmed negative evidence and absent/unmeasured evidence.

### 7.2 Incomplete Contradiction Rules (`trace_generator.py:98-110`)
Contradiction checking logic is restricted to:
```python
if disease == "SBRAD" and hr >= 60:
    contradiction = True
elif disease == "STACH" and hr <= 100:
    contradiction = True
```
- **Defect:** No contradiction rules are implemented for AFIB (e.g. irregular RR intervals), RBBB (e.g. QRS $>120\text{ ms}$ with rsR' in V1), LBBB (e.g. broad monophasic R in I/V6), 1AVB (e.g. PR $>200\text{ ms}$), MI (e.g. ST elevations/Q waves), or NORM.
- **Reporting Stance:** Traces with top hypotheses in these six diseases are strictly classified as **"Insufficient evidence to assess"** (67.5% of all traces). They are not reported as verified passes.

### 7.3 Epistemological Limitations of Attention Weights
- Cross-attention weights represent mathematical routing correlations between token representations within the transformer's latent space.
- They do **not** represent causal reliance or faithful clinical deductions.
- A natural-language trace generated from attention weights reflects post-hoc summarization, not a faithful exposure of internal model reasoning.

---

## 8. Artifact Directory Inventory

All generated artifacts have been written to the non-overwriting validation directory and cross-copied to reports:

| Artifact Name | Relative Path | Size | Description |
| :--- | :--- | :---: | :--- |
| **12-lead Traces** | `runs/module4_v3/validation_traces/traces_validation_12-lead.json` | 15.86 MB | 3,688 full JSON dossiers for 12-lead validation |
| **10-lead Traces** | `runs/module4_v3/validation_traces/traces_validation_10-lead.json` | 15.95 MB | 3,688 full JSON dossiers for 10-lead validation |
| **8-lead Traces** | `runs/module4_v3/validation_traces/traces_validation_8-lead.json` | 16.03 MB | 3,688 full JSON dossiers for 8-lead validation |
| **6-lead Traces** | `runs/module4_v3/validation_traces/traces_validation_6-lead.json` | 16.05 MB | 3,688 full JSON dossiers for 6-lead validation |
| **4-lead Traces** | `runs/module4_v3/validation_traces/traces_validation_4-lead.json` | 16.11 MB | 3,688 full JSON dossiers for 4-lead validation |
| **2-lead Traces** | `runs/module4_v3/validation_traces/traces_validation_2-lead.json` | 16.10 MB | 3,688 full JSON dossiers for 2-lead validation |
| **1-lead Traces** | `runs/module4_v3/validation_traces/traces_validation_1-lead.json` | 16.10 MB | 3,688 full JSON dossiers for 1-lead validation |
| **Trace Inventory CSV** | `runs/module4_v3/validation_traces/validation_trace_inventory.csv` | 2.70 KB | Machine-readable inventory with hashes & coverage |
| **Trace Findings CSV** | `runs/module4_v3/validation_traces/validation_trace_findings.csv` | 3.38 KB | Audited findings and defect classifications |
| **Reports Copy - Inv** | `runs/module4_v3/reports/validation_trace_inventory.csv` | 2.70 KB | Identical copy in reports directory |
| **Reports Copy - Findings** | `runs/module4_v3/reports/validation_trace_findings.csv` | 3.38 KB | Identical copy in reports directory |
| **Generation Report** | `runs/module4_v3/reports/validation_trace_generation_report.md` | *(This file)* | Comprehensive synthesis and audit report |

---

## 9. Final Verification Dashboard & Stop Condition

### 9.1 Verification Checklist
- [x] **No Test Access:** Zero test records loaded, inspected, or evaluated. Quarantine remained fail-closed throughout.
- [x] **Artifact Preservation:** Checkpoints, training scripts, calibration parameters, split manifests, and Module 1–3 artifacts remain unchanged.
- [x] **Zero Weight Updates:** Frozen model weights (`control_reasoning_best_seed42.pt`) were used strictly in `eval()` mode. No backpropagation or fine-tuning occurred.
- [x] **Output Containment:** All newly created outputs are confined to `runs/module4_v3/validation_traces/` and `runs/module4_v3/reports/`.
- [x] **Evidence-Consistency Documented:** Limitations of attention faithfulness, zero-embedding conflation, and incomplete contradiction rules are fully stated.
- [x] **Patient Unit Accuracy:** 25,816 evaluations across 3,688 validation records from 3,394 unique patient clusters are documented accurately.

### 9.2 Stop Condition
With the completion of validation trace generation, multi-configuration evidence auditing, inventory creation, and final reporting, the Phase 1 reasoning-trace mandate is complete. 

In strict adherence to the task instructions:
- No model retraining has been initiated.
- No Module 4 v4 implementation has been started.
- No baseline correction or test-set evaluation has been executed.
